Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (461-470 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|December 6, 2021
Splenic infarction in sickle cell trait: A comprehensive systematic review of case studiesJamal M Jefferson, Wynton M Sims, Nkeiruka Umeh, et al.
Ejhaem|January 6, 2022
New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCLMadiha Iqbal, Bipin N Savani, Mehdi Hamadani
Ejhaem|July 18, 2022
Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patientsJohn Girdlestone, Meera Raymond, Bronwen Shaw, et al.
Ejhaem|July 18, 2022
Bone marrow infiltration pattern in patients with intravascular large B-cell lymphoma diagnosed by random skin biopsyKosei Matsue, Yoshiaki Abe, Kentaro Narita, et al.
Ejhaem|July 18, 2022
A retrospective analysis of venous thromboembolism trends in chemotherapy-induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administrationEmily J Bryer, Michael J Kallan, Ting-Shan Chiu, et al.
Ejhaem|July 18, 2022
Inhibition of cyclin-dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphomaXiaoxian Zhao, Juraj Bodo, Ruoying Chen, et al.
Ejhaem|July 18, 2022
Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survivalTor Persson Skare, Elin Sjöberg, Mattias Berglund, et al.
Ejhaem|July 18, 2022
DNMT1 and p38γ are inversely expressed in reactive non-metastatic lymph nodes burdened with colorectal adenocarcinomaXu Hannah Zhang, Zhirong Yin, Aimin Zhang, et al.
Ejhaem|July 18, 2022
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomibPaul G Richardson, Arnon Nagler, Dina Ben-Yehuda, et al.
Ejhaem|July 18, 2022
Relapse of follicular lymphoma arising from a non-t(14;18) cloneYasuyuki Otsuka, Momoko Nishikori, Masakazu Fujimoto, et al.
Pageof 93

Showing results (461-470 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|December 6, 2021
Splenic infarction in sickle cell trait: A comprehensive systematic review of case studiesJamal M Jefferson, Wynton M Sims, Nkeiruka Umeh, et al.
Ejhaem|January 6, 2022
New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCLMadiha Iqbal, Bipin N Savani, Mehdi Hamadani
Ejhaem|July 18, 2022
Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patientsJohn Girdlestone, Meera Raymond, Bronwen Shaw, et al.
Ejhaem|July 18, 2022
Bone marrow infiltration pattern in patients with intravascular large B-cell lymphoma diagnosed by random skin biopsyKosei Matsue, Yoshiaki Abe, Kentaro Narita, et al.
Ejhaem|July 18, 2022
A retrospective analysis of venous thromboembolism trends in chemotherapy-induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administrationEmily J Bryer, Michael J Kallan, Ting-Shan Chiu, et al.
Ejhaem|July 18, 2022
Inhibition of cyclin-dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphomaXiaoxian Zhao, Juraj Bodo, Ruoying Chen, et al.
Ejhaem|July 18, 2022
Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survivalTor Persson Skare, Elin Sjöberg, Mattias Berglund, et al.
Ejhaem|July 18, 2022
DNMT1 and p38γ are inversely expressed in reactive non-metastatic lymph nodes burdened with colorectal adenocarcinomaXu Hannah Zhang, Zhirong Yin, Aimin Zhang, et al.
Ejhaem|July 18, 2022
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomibPaul G Richardson, Arnon Nagler, Dina Ben-Yehuda, et al.
Ejhaem|July 18, 2022
Relapse of follicular lymphoma arising from a non-t(14;18) cloneYasuyuki Otsuka, Momoko Nishikori, Masakazu Fujimoto, et al.
Pageof 93